0001104659-23-027555.txt : 20230301
0001104659-23-027555.hdr.sgml : 20230301
20230301214627
ACCESSION NUMBER: 0001104659-23-027555
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221004
FILED AS OF DATE: 20230301
DATE AS OF CHANGE: 20230301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: De Paolantonio Ernest Robert
CENTRAL INDEX KEY: 0001588538
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41063
FILM NUMBER: 23696219
MAIL ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Journey Medical Corp
CENTRAL INDEX KEY: 0001867066
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 471879539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9237 E VIA DE VENTURA BLVD., SUITE 105
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85258
BUSINESS PHONE: 480-434-6670
MAIL ADDRESS:
STREET 1: 9237 E VIA DE VENTURA BLVD., SUITE 105
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85258
4/A
1
tm237728-1_4aseq1.xml
OWNERSHIP DOCUMENT
X0306
4/A
2022-10-04
2022-10-06
1
0001867066
Journey Medical Corp
DERM
0001588538
De Paolantonio Ernest Robert
C/O JOURNEY MEDICAL CORPORATION,
9237 E VIA DEVENTURA BLVD., SUITE 105
SCOTTSDALE
AZ
85258
0
1
0
0
See Remarks
Common Stock, par value $0.0001 per share
2022-10-04
4
S
0
10093
2.41
D
259907
D
In connection with the vesting of 40,000 shares on October 1, 2022, a total of 10,093 of such shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
Due to a clerical error, the original Form 4 filed on October 6, 2022 reflected an acquisition of 10,029 shares in lieu of a disposition of 10,029 shares. The amount of securities beneficially owned following the reported transaction reported in the previously filed Form 4 is correct.
Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on October 4, 2022, was $2.38 to $2.43. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares sold at each separate price.
Includes restricted stock units, which vest over various time periods.
As of the date of the original Form 4 filed on October 6, 2022, the Reporting Person was the Chief Financial Officer of the Issuer. In a Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 20, 2023, the Issuer announced that the Reporting Person provided notice of his resignation to the Issuer on January 16, 2023 and, as such, is no longer a Section 16 filer as of the date of this amendment.
/s/ Ramsey Alloush, attorney-in-fact
2023-03-01